What L7 Informatics does

L7 Informatics is a private life sciences software company founded in 2011 and headquartered in Austin, Texas, with 101-250 employees and $38 million in disclosed funding. It builds and sells L7|ESP, a unified digital platform that orchestrates end-to-end scientific and manufacturing workflows across research, development, manufacturing, and quality in GxP-regulated environments. The platform is built on an ontology-driven knowledge graph that contextualizes data at the point of execution, capturing full relationships between samples, materials, instruments, personnel, and outcomes rather than producing flat records. Built-in applications include L7 LIMS, L7 Notebooks (ELN), L7 MES, and L7 Scheduling, with adjacent modules for inventory, equipment management, stability, biorepository, and location management. Component modules include L7|MASTER (low-code authoring), L7|HUB (FAIR content repository with instrument connectors), L7|INTELLIGENCE (BI/analytics export to Snowflake, Tableau, Power BI), L7|SYNAPSE (agentic AI layer launched April 2026), and L7|EXCHANGE (multi-party orchestration, planned 2027).

The company operates an enterprise SaaS business model with subscription licensing on annual billing cycles, deployable via cloud, on-premises, or hybrid configurations. Pricing is quote-based and not publicly disclosed, sold through direct enterprise field sales augmented by strategic/implementation, technology, and OEM/reseller partners. Customer segments are primarily enterprise and include pharmaceutical companies, biotechs (particularly advanced therapeutics and cell/gene therapy), CDMOs, diagnostics organizations, CROs, academic and cancer research institutions, ag-bio companies, and life science tools providers. Named customers include QIAGEN, Dana-Farber Cancer Institute, The Jackson Laboratory, Cellipont Bioservices, CTMC, Cellares, GeneDx, Cibus, Alpine Bio, Gradalis, and CSI-Dx. Strategic priorities include the agentic AI layer, multi-party orchestration, and the Leica Biosystems pathology partnership (announced November 2025, commercial early 2026).

Name

L7 Informatics

Legal name

L7 Informatics, Inc.

Website

https://l7informatics.com

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

101–250 employees

Short description

L7 Informatics builds L7|ESP, an ontology-driven unified platform that orchestrates workflows and contextualizes data across research, development, manufacturing, and quality for regulated pharmaceutical, biotech, CDMO, diagnostics, and research customers.

Ownership category

akta.pro rank

Product category

Life Sciences Workflow Orchestration Software

NAICS

Software Publishers (5132), Computer Systems Design and Related Services (54151)

SIC

Services-Prepackaged Software (7372), Services-Computer Integrated Systems Design (7373)

akta.pro primary industry

Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D) (HLAGAJAC)

akta.pro secondary industries

Quality, Compliance & Validation Software for Labs (GxP/CSV, eQMS for QC Labs) (HLAGAJAI), Knowledge Management & Scientific Collaboration / Literature Intelligence (HLAGAJAN), Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)

Keywords

• Laboratory informatics software
• Workflow orchestration software
• GxP compliance software
• Scientific data management
• Manufacturing execution systems

Headquarters

HQ city

Austin

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Software Platform Subscription: L7 Informatics generates revenue primarily through licensing and subscription fees for its L7|ESP unified platform and associated applications (L7 LIMS, L7 MES, L7 Notebooks, L7 Scheduling). The platform is offered via cloud, on-premises, or hybrid deployment models, suggesting a recurring subscription revenue structure. Professional services for implementation, compliance, support, and training further complement the revenue model.

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels9 records

Core offering

L7 Informatics develops and sells L7|ESP (Enterprise Science Platform), a unified digital platform for regulated life sciences that contextualizes data at the point of execution and orchestrates end-to-end scientific and manufacturing workflows across research, development, manufacturing, and quality. The platform is built on an ontology-driven knowledge graph and includes built-in LIMS, ELN, MES, and Scheduling applications, with optional deployment via cloud, on-premises, or hybrid models to meet GxP compliance requirements.

Product overview

L7 Informatics offers L7|ESP®, a unified digital platform architecture for regulated life sciences that combines a core execution layer with modular components and best-of-breed applications. The platform components include L7|MASTER® for data and process modeling, L7|HUB® for content repository and FAIR data management, L7|INTELLIGENCE® for data intelligence and export to BI tools, L7|SYNAPSE™ for agentic AI capabilities, and L7|EXCHANGE™ for multi-party orchestration (estimated 2027 release). Built-in applications include L7 LIMS, L7 MES, L7 Notebooks (ELN), L7 Scheduling, L7 Inventory, L7 EM, L7 Stability, L7 Biorepository, and L7 Location—all integrated within the unified platform with workflow orchestration, ontology-driven data contextualization, and AI-actionable data.

Differentiator

Problem solved

Functional benefit

Brands

• L7|ESP: The Enterprise Science Platform - a unified digital platform that contextualizes data at the point of execution and orchestrates workflows across research, development, manufacturing, and quality for regulated life sciences.
• L7|MASTER
• L7|HUB
• L7|INTELLIGENCE
• L7|SYNAPSE
• L7|EXCHANGE
• L7 LIMS
• L7 MES
• L7 Notebooks
• L7 Scheduling
• L7 UNIVERSITY

Products and services

• L7|ESP® (Enterprise Science Platform)

Quantifiable outcome

• Customer-reported efficiency gains of up to 80% after replacing manual or siloed processes with L7|ESP
• +3 more outcomes

Named customers14 records

Segments9 records

Ideal customer profiles6 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Integration21 records

AI capability7 records

Feature10 records

Partnerships

Three partnerships are on record, tiered core and minor.

• Leica BiosystemscoreStrategic or Co-development Partner · 29 December 2025Leica Biosystems and L7 Informatics formed a strategic partnership to develop an AI-ready pathology platform integrating L7 Informatics' Enterprise Science Platform (L7|ESP) with Leica Biosystems' instrumentation. The collaboration addresses operational challenges in pathology laboratories including siloed data systems, rising diagnostic demands, and workforce shortages. Commercial product availability expected in early 2026. The unified platform is designed to automate workflows and enable AI-driven decision support across the entire pathology workflow from biopsy to diagnosis.
• Strategic and Implementation PartnersminorImplementation/ SI/ Consulting PartnerL7 Informatics partners with strategic and implementation partners to help customers achieve full potential and ensure positive outcomes. These partners provide services including operations assessment, data + process architecture, implementation, compliance, and support, helping businesses achieve full potential and ensure positive outcomes with L7 ESP.
• OEM and Reseller PartnersminorChannel Partner/ Reseller/ DistributorOEM partners leverage the power of L7 ESP to bring new digital infrastructure to their customers that unlocks the power of true data intelligence. Reseller partners extend L7's reach to new customer segments.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Dassault Systèmes BIOVIA: BIOVIA provides a broad scientific platform covering lab informatics, ELN, LIMS, and molecular modeling for regulated life sciences. Its enterprise breadth and global install base position it as a broad incumbent competing with L7 ESP across multiple workflow areas.
• Thermo Fisher Scientific (SampleManager LIMS / Chromeleon): Thermo Fisher offers enterprise LIMS and lab informatics software tied to its instrument portfolio, including SampleManager LIMS for regulated labs. It competes with L7 LIMS and instrument connector ecosystem in QC and regulated manufacturing.
• Veeva Systems: Veeva is a dominant cloud software provider for life sciences, spanning clinical, regulatory, quality, and commercial domains. Its Vault LIMS and quality/regulatory suites overlap with L7's platform breadth and target the same GxP-regulated enterprise buyers.

Direct peers

• Benchling: Benchling is a cloud-native biotech R&D platform offering LIMS, ELN, and workflow orchestration for life sciences R&D. It competes most directly with L7's LIMS, ELN (Notebooks), and unified platform vision for biotech and pharma customers, with overlap in cell/gene therapy and biologics workflows.
• Dotmatics: Dotmatics provides a scientific R&D informatics platform (LIMS, ELN, data management, decision support) for pharma and biotech. It competes with L7 ESP in the lab informatics and data contextualization category, particularly for discovery and translational research customers.
• LabWare: LabWare is one of the largest independent LIMS providers, serving regulated pharma, biotech, and clinical labs with configurable LIMS and ELN solutions. It is a direct competitor to L7 LIMS and L7 Notebooks in the same regulated buyer accounts L7 targets.
• Sapio Sciences: Sapio Sciences provides a unified lab informatics platform combining LIMS, ELN, and scientific data management with low-code configuration, targeting biotech and clinical labs. Its unified, configurable approach directly parallels L7 ESP's integrated platform strategy.
• Genedata: Genedata offers an enterprise platform for biopharma R&D, covering screening, omics, biologics, and bioprocess data management. It competes with L7's workflow orchestration and data contextualization for biopharma R&D workflows.

Emerging players

• TetraScience: TetraScience operates a scientific data cloud that ingests and harmonizes lab instrument data for life sciences R&D and manufacturing. It overlaps with L7's instrument connector library and data contextualization thesis, but focuses on data infrastructure rather than end-to-end workflows.
• Scitara: Scitara provides a Scientific Data Exchange (SDX) platform for instrument-to-enterprise data integration in labs. It overlaps with L7's instrument connector ecosystem and L7|EXCHANGE multi-party orchestration roadmap, particularly for instrument-driven workflows.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/l7informatics
• YouTubeyoutube.com/@l7informatics185
• LinkedInlinkedin.com/company/l7informatics

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds8 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about L7 Informatics